Regeneron Pharmaceuticals Inc. buy Piper Sandler
Start price
18.05.26
/
50%
€538.80
Target price
18.05.27
€735.81
Performance (%)
9.08%
Price
19:07
€586.80
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 9.08%. Dividends of €0.94 are taken into consideration when calculating the performance. This prediction currently runs until 18.05.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | -2.451% | -2.451% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Piper_Sandler for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals (REGN) had its price target lowered by Piper Sandler from $875.00 to $855.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€581.60
09.07.26
09.07.26
€747.34
09.07.27
09.07.27
0.89%
19:07
19:07
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€666.40
31.03.26
31.03.26
€762.30
31.03.27
31.03.27
-11.80%
19:07
19:07
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€652.60
27.01.25
27.01.25
€964.27
27.01.26
27.01.26
-1.93%
28.01.26
28.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€780.20
01.11.24
01.11.24
€1,099.4
01.11.25
01.11.25
-27.20%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,072.0
23.08.24
23.08.24
€1,109.7
23.08.25
23.08.25
-53.25%
24.08.25
24.08.25